Bedrijfsoverzicht
Aspen Aerogels, Inc. is an aerogel technology enterprise dedicated to the design, development, manufacturing, and commercialization of advanced insulation materials for the energy industrial, sustainable insulation, and electric vehicle markets across the United States, Canada, Asia, Europe, and Latin America. The company operates within the Industrials sector, specifically in the Building Products & Equipment industry, positioning itself as a provider of specialized thermal management solutions. Aspen Aerogels, Inc. holds a market capitalization of $276.64M, which reflects its status as a mid-sized entity in the industrial materials space. With an annual revenue of $271.10M and an employee base of 854, the company demonstrates a significant operational footprint despite its relatively modest market valuation. These figures indicate that the firm has established a substantial production and sales infrastructure, yet the market cap suggests that investors are currently pricing the stock with caution, likely due to recent financial performance challenges or high valuation multiples relative to its size.
Financiële gezondheid
The company reported total revenue of $271.10M over the trailing twelve months, yet it simultaneously posted a net income loss of $389.55M and an EBITDA of -$6.24M. The substantial gap between positive revenue and a massive net income deficit reveals a severely distressed cost structure where expenses, particularly operating costs and potentially significant restructuring or impairment charges, vastly exceed earnings before interest and taxes. Despite the net income loss, the company generated free cash flow of $29.47M, which provides a degree of financial flexibility by ensuring that operations are generating cash sufficient to cover capital expenditures and debt service obligations. However, the financial picture is further complicated by a cash balance of $156.86M against total debt of $143.71M, resulting in a debt-to-equity ratio of 61.02. This high leverage ratio indicates that the balance sheet is heavily leveraged, as equity is relatively small compared to the total debt load, creating a sensitive capital structure. On the liquidity front, the current ratio stands at 3.90, which indicates strong short-term liquidity and a robust ability to cover immediate obligations with current assets. Nevertheless, the return metrics paint a picture of management ineffectiveness in generating value, evidenced by a return on equity of -91.6% and a return on assets of -4.9%. These negative returns confirm that the management team is currently destroying shareholder value and utilizing assets inefficiently to generate profit.
Waarderingsbeoordeling
The valuation metrics present a complex picture, with a trailing P/E ratio of N/A and a forward P/E of -835.00. The disparity between a non-existent trailing P/E and a negative forward P/E implies that the market expects earnings to remain negative or for the company to struggle to turn profitable in the near term. The price-to-book ratio is 1.17, which indicates that the stock is trading at a slight premium over its book value, suggesting investors are paying more for the company's tangible assets than their accounting value. Alternative valuation metrics include a price-to-sales ratio of 1.02 and an EV/EBITDA of -42.26, which suggest that the stock is being valued primarily on its sales revenue rather than profitability, a common characteristic for distressed growth stocks. Regarding trading range, the 52-week high is $9.78 and the 52-week low is $2.30. While the exact current price is not provided in the source data, the forward P/E of -835.00 combined with the negative earnings implies the current trading price is significantly depressed relative to historical highs, reflecting the severe market discount applied to the stock. The beta value is 2.90, which means the stock exhibits extreme price volatility and is nearly three times as sensitive to movements in the broader market as the S&P 500.
Growth & Income
The company experienced a revenue growth of -66.4% year-over-year, while earnings growth is listed as N/A due to the negative earnings baseline. Since earnings are negative, the concept of earnings growing faster than revenue does not apply in a traditional sense, as the primary challenge is reversing the massive net loss rather than expanding profit margins on top of shrinking sales. Aspen Aerogels, Inc. does not pay dividends, as indicated by a dividend yield of N/A and a payout ratio of 0.0%. Consequently, the company does not distribute earnings to shareholders but instead retains all resources, which in this context is necessary to fund operations and service its substantial debt obligations. The overall growth and income profile is characterized by significant revenue contraction and a complete absence of current profitability or dividend income, highlighting a high-risk investment thesis focused entirely on potential future operational turnaround.